This review bridges this gap by synthesizing mechanistic insights across MND diseases such as ALS, PLS, HSP, SBMA, SMARD1, MSP, IBMPFD, and aSMA, revealing how converging molecular pathways underpin disease progression. Here, IGHMBP2 is linked to mild neurocognitive disorder.